Dai-Ichi Karkaria Ltd (526821) — Multibagger Analysis

AI research on 1 Expansion / Order-win announcement by Dai-Ichi Karkaria Ltd since August 2026 — deal magnitude, revenue and EPS impact, execution risk, and the actual return since each announcement measured from the next trading day's open and benchmarked against the Nifty Smallcap 250.

Board Meeting - Outcome of Board Meeting

13 August 2026 · Expansion · Possible · Specialty Chemicals · score 52/100

Deal

Deal value—

Deal vs businessQ1 FY27 revenue of Rs 57.84 Cr represents ~36% of full TTM revenue (Rs 161 Cr)

Execution period—

Fundamental gradeC

AI projections

Revenue uplift (yr1 / steady)35.0% / 40.0%

EPS uplift150.0%

Upside base / bull / bear45.0% / 85.0% / -30.0%

Horizon12-24 months

Realized market record

Entry — next-day open (14 Aug 2026)₹337.9

Latest close (16 Sep 2026)₹313.5

Return since-7.2%

α vs Smallcap 250-4.5%

Positives

Sharp top-line expansion with Q1 FY27 consolidated revenue growing 46.6% YoY to Rs 57.84 Cr.
Strong earnings turnaround to consolidated PAT of Rs 2.93 Cr (EPS Rs 3.93) and standalone PAT of Rs 6.09 Cr.
Solid balance sheet support with net worth at Rs 184 Cr, low debt of Rs 13 Cr (D/E 0.07), and price-to-book of 1.3x.
Stable promoter ownership at 64.0% providing governance continuity.

Risks

Significant raw material cost exposure: Cost of materials consumed surged to 69.6% of revenue in Q1 FY27.
Drag from subsidiaries: Consolidated PAT (Rs 2.93 Cr) substantially trails standalone PAT (Rs 6.09 Cr).
Material related-party transactions with limits up to Rs 50 Cr each with JV ChampionX and raw material vendor Indian Oxides.
Historical profitability inconsistency with FY26 trailing OPM of 2.1% and negative trailing ROCE of -1.0%.

Governance flags

Material related-party transactions with Indian Oxides (raw material procurement limit Rs 50 Cr) and JV ChampionX (sales limit Rs 50 Cr), sizable relative to TTM revenue of Rs 161 Cr.

Full AI brief

Analytical Assessment: Dai-ichi Karkaria Limited (526821)

Analysis Date: 2026-08-13

1. Catalyst Evaluation & Ramp-Aware Impact Math

On August 13, 2026, Dai-Ichi Karkaria reported its Q1 FY27 consolidated financial results showing a sharp operational turnaround: - Revenue from Operations: Rs 57.84 Cr (+46.6% YoY vs Rs 39.45 Cr in Q1 FY26). - Consolidated PAT: Rs 2.93 Cr (vs Rs 0.02 Cr in Q1 FY26). - Standalone PAT: Rs 6.09 Cr (surpassing full-year FY26 results). - Q1 Consolidated EPS: Rs 3.93.

Revenue & Earnings Calculation:

TTM Revenue prior to Q1: Rs 161.0 Cr.
Annualized Q1 Run-Rate Revenue: Rs 57.84 Cr * 4 = Rs 231.36 Cr.
Implied Revenue Uplift: +43.7% over FY26 TTM revenue.
Annualized Q1 Run-Rate EPS: Rs 3.93 * 4 = Rs 15.72.
Implied P/E Valuation: At the current market price of Rs 319.4, an annualized EPS of Rs 15.72 yields a forward P/E of ~20.3x, compared to the industry peer median trailing P/E of 30.6x.

2. Industry Context & Operational Risk

Industry: Specialty Chemicals (Surfactants, Polymers, Oilfield Chemicals).
Capital Intensity: Medium.
Expected Industry CAGR: 10.0% - 12.0%.
Execution Complexity: Moderate. Raw material costs (crude derivatives) reached 69.6% of sales in Q1 FY27. Key operational challenges involve managing raw material volatility and resolving subsidiary drags.

3. Fundamental Quality & Governance Check

Trailing ROCE: -1.0% (FY26 loss drag).
Balance Sheet: Net worth Rs 184 Cr, Debt Rs 13 Cr (D/E 0.07).
Promoter Shareholding: Stable at 64.0%.
Governance Note: Heavy reliance on related party transactions (Rs 50 Cr cap with Indian Oxides for raw materials, Rs 50 Cr cap with JV ChampionX) requires monitoring.

4. Valuation Scenarios & Horizons (12–24 Months)

Base Case (+45% to Rs 463): Sustained quarterly revenue run-rate around Rs 50-55 Cr with annual PAT of Rs 12-14 Cr (EPS ~Rs 16-18) re-rating to 25x forward earnings.
Bull Case (+85% to Rs 590): Standalone margins flow through to consolidated level (PAT >Rs 20 Cr, EPS >Rs 25) with peer multiple re-rating toward 23-25x.
Bear Case (-30% to Rs 223): Raw material margin pressure resumes, operational costs rebound, and consolidated PAT drops back to zero/negative levels.

5. Verdict Rationale

Dai-ichi Karkaria presents a classic micro-cap turnaround play (Market Cap Rs 239 Cr). While trailing metrics failed the quality gate, Q1 FY27 results mark a material inflection point. High related-party transaction volumes and historical margin volatility cap the verdict at POSSIBLE with a 0.70 confidence level.

Analysis as of 2026-08-13 (price ₹319.40) · AI research, not investment advice.

FollowTelegram

Verdicts and projections on this page are produced by an AI model from Dai-Ichi Karkaria Ltd's public exchange filings and are not investment advice. "Return since" is measured from the opening price of the next trading day after each announcement to the latest available close, so it reflects a price an investor could actually have paid. See all analysed companies on Multibagger AI.